Molecular Partners AG American Depositary Shares

Molecular Partners AG, a clinical-stage biotech company developing DARPin therapeutics, will present its latest developments and 2025 outlook at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2025.

Get the latest financial updates and insights with Wall Street Breakfast's daily podcast available on Seeking Alpha, iTunes, and Spotify.

Upgrades According to Argus Research, the prior rating for AstraZeneca PLC (NASDAQ:AZN) was changed from Hold to Buy. For the second quarter, AstraZeneca had an EPS of $0.86, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $71.70 and a 52-week-low of $55.50. AstraZeneca closed at $66.32 at the end of the ...

MOLN earnings call for the period ending December 31, 2021.

Regulatory and other pipeline updates from Biogen (BIIB) and AMGN are among a few key highlights from the biotech sector during the past week.